Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

There has been a big movement in oncology research to establish new biomarkers as they are an earlier measure of activity in the body's cells. p21 has been proven to play a critical role in cell cycle arrest leading to cell death. No one has been able to validate it as a biomarker, to the best of our knowledge, so this will be a major event not only for Cellceutix, but for the cancer clinical trials. Increased levels of p21 are not only a predictor of cell death, but a benchmark in judging effectiveness of Kevetrin. -Menon

"Early cohort P21 data is not impressive at all".... Sigh.